This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fred Hutchinson Cancer Center. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Mesfin Gewe: Innovator in Cancer Treatment
Introduction
Mesfin Gewe is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the creation of NKG2D decoys, which have the potential to revolutionize therapeutic approaches in oncology and immunology.
Latest Patents
Mesfin Gewe holds 1 patent for his invention of NKG2D decoys. These decoys are designed to have high affinity and avidity for both surface-bound and soluble NKG2D ligands. The applications of these decoys are extensive, including the identification of NKG2D ligands, treatment of cancer, management of graft vs. host disease (GVHD), and addressing various inflammatory conditions. Additionally, they can enhance immune responses against vaccines, showcasing their versatility in medical applications.
Career Highlights
Mesfin Gewe is affiliated with the Fred Hutchinson Cancer Center, where he conducts his research. His work at this esteemed institution has positioned him as a key player in the fight against cancer. His innovative approaches and dedication to research have garnered attention in the scientific community.
Collaborations
Some of Mesfin Gewe's notable coworkers include Peter Rupert and Roland K Strong. Their collaborative efforts contribute to the advancement of research in cancer treatment and immunology.
Conclusion
Mesfin Gewe's contributions to the field of cancer treatment through his invention of NKG2D decoys highlight his role as an influential inventor. His work not only addresses critical medical challenges but also paves the way for future innovations in therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
